Global Intravenous Therapy and Vein Access Market Size,
The Global Intravenous (IV) Therapy and Vein Access Market size is expected to reach $33. 6 billion by 2028, rising at a market growth of 5. ...
Stay updated with breaking news from Peripheral Advantage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Global Intravenous (IV) Therapy and Vein Access Market size is expected to reach $33. 6 billion by 2028, rising at a market growth of 5. ...
What You Should Know: – B. Braun Medical Inc. (B. Braun), a provider of infusion therapy and pain management, unveiled Peripheral Advantage, a new program that is designed to improve patients’ experience with peripheral intravenous (IV) therapy. – The comprehensive program combines clinical instruction, data-driven insights and advanced tools to empower nurses to achieve first-stick success and help prevent many of the complications associated with peripheral IV therapy. – Peripheral Advantage, which is now available to all hospitals nationwide, addresses a long tolerated,...
Share this article BETHLEHEM, Pa., April 29, 2021 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today unveiled Peripheral Advantage ®, a new program that is designed to improve patients' experience with peripheral intravenous (IV) therapy. The comprehensive program combines clinical instruction, data-driven insights and advanced tools to empower nurses to achieve first-stick success and help prevent many of the complications associated with peripheral IV therapy. Peripheral Advantage, which is now available to all hospitals nationwide, a...